Pharmacokinetics of granisetron in rat blood and brain by microdialysis.
To characterize the pharmacokinetics of protein-free granisetron in blood and brain we implanted microdialysis probes into the jugular vein and cerebral frontal cortex of the rat. Granisetron (3 or 6 mg/kg, i.v., n=6) was then administered, and microdialysates from blood and brain were collected from both sites and assayed by a validated high-performance liquid chromatographic method. Pharmacokinetics parameters were calculated from the corrected dialysate concentrations of granisetron versus time data. The elimination half-lives of granisetron in blood and brain were 51.3+/-5.5 and 69.7+/-6.3 min for 6 mg/kg, and 50.7+/-4.3 and 74.3+/-12.5 min for 3 mg/kg, respectively. Granisetron rapidly entered the extracellular fluid of cerebral frontal cortex at Tmax of 24 min. The results suggest that simultaneous microdialysis in blood and brain can be usefully applied to study the pharmacokinetics of granisetron in the periphery and the central nervous system.
Huang
C T
CT
Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan.
Chen
C F
CF
Tsai
T H
TH
D000818:Animals; D001921:Brain / Q000378:metabolism*; D017829:Granisetron / Q000493:pharmacokinetics*; D006207:Half-Life; D008297:Male; D017551:Microdialysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012702:Serotonin Antagonists / Q000493:pharmacokinetics*
D017829:Granisetron; D012702:Serotonin Antagonists